Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery

NCT ID: NCT00411489

Last Updated: 2008-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Roux-En-Y gastric bypass procedure is the most commonly performed bariatric procedure in the United States. Despite initial weight loss, some patients experience weight regain that may be related to an increase in the size of the gastric pouch and/or stoma. A second surgical procedure to reduce the size of the pouch and/or stoma is typically associated with a higher risk of death or complications than the original gastric bypass procedure. This study will evaluate a less invasive, endolumenal alternative to pouch and stoma revision as a means of producing weight loss in patients who have regained weight following gastric bypass.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endolumenal surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 yrs of age or older and \< 65 yrs of age
* At least 2 yrs post-Roux-En-Y gastric bypass surgery
* Initially achieved at least 50% weight loss
* At enrollment, has regain at least 15% of weight loss
* BMI 40 or greater or 35 or greater with one or more co-morbidities
* Stoma diameter at least 20 mm
* Completes successful nutritional screening
* Is a candidate for a surgical revision procedure
* Is a reasonable risk to undergo general anesthesia
* Completes successful cardiopulmonary evaluation
* ASA Classification of less than or equal to III
* Able to provide written consent
* Able to return for protocol-specified evaluations

Exclusion Criteria

* Esophageal stricture or other anatomy/condition that precludes passage of endolumenal instruments
* Previous bariatric revision procedure
* Has another causal factor for weight regain other than stoma or pouch dilatation
* Non-mobile or has significant impairment of mobility that will limit compliance with post-op exercise program
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

USGI Medical

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lee L Swanstrom, MD

Role: PRINCIPAL_INVESTIGATOR

Oregon Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lahey Clinic

Burlington, Massachusetts, United States

Site Status

Mt. Sinai School of Medicine

New York, New York, United States

Site Status

Columbia-Presbyterian Medical Center

New York, New York, United States

Site Status

Oregon Clinic

Portland, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TP0165

Identifier Type: -

Identifier Source: secondary_id

TP0165

Identifier Type: -

Identifier Source: org_study_id